United Arab Emirates

Last Updated 14 June 2021.

4 Vaccines Approved for Use in United Arab Emirates

• Pfizer/BioNTech
  BNT162b2

  • Phase 1
  • Phase 2
  • Phase 3
  • Approved

  This vaccine is approved.

  Approved in 88 countries

  26 trials in 15 countries

  RNA

• Gamaleya
  Sputnik V

  • Phase 1
  • Phase 2
  • Phase 3
  • Approved

  This vaccine is approved.

  Approved in 68 countries

  19 trials in 6 countries

  Non Replicating Viral Vector

• Oxford/AstraZeneca
  AZD1222

  • Phase 1
  • Phase 2
  • Phase 3
  • Approved

  This vaccine is approved.

  Approved in 110 countries

  32 trials in 19 countries

  Non Replicating Viral Vector

• Sinopharm (Beijing)
  BBIBP-CorV

  • Phase 1
  • Phase 2
  • Phase 3
  • Approved

  This vaccine is approved.

  Approved in 53 countries

  6 trials in 7 countries

  Inactivated

3 Vaccines in Clinical Trials in United Arab Emirates

• Gamaleya
  Sputnik V

  • Phase 1
  • Phase 2
  • Phase 3
  • Approved

  This vaccine is approved.

  Approved in 68 countries

  19 trials in 6 countries

  Non Replicating Viral Vector

• Sinopharm (Beijing)
  BBIBP-CorV

  • Phase 1
  • Phase 2
  • Phase 3
  • Approved

  This vaccine is approved.

  Approved in 53 countries

  6 trials in 7 countries

  Inactivated

• Sinopharm (Wuhan)
  Inactivated (Vero Cells)

  • Phase 1
  • Phase 2
  • Phase 3
  • Approved

  This vaccine is approved.

  Approved in 1 country

  8 trials in 7 countries

  Inactivated